146 related articles for article (PubMed ID: 20377409)
1. Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy.
Aurpibul L; Puthanakit T; Sirisanthana T; Sirisanthana V
Clin Infect Dis; 2010 May; 50(10):1415-8. PubMed ID: 20377409
[TBL] [Abstract][Full Text] [Related]
2. Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy.
Aurpibul L; Puthanakit T; Sirisanthana T; Sirisanthana V
Clin Infect Dis; 2007 Sep; 45(5):637-42. PubMed ID: 17683001
[TBL] [Abstract][Full Text] [Related]
3. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.
Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW
Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077
[TBL] [Abstract][Full Text] [Related]
4. Measles-mumps-rubella revaccination; 18 months vs. 4-6 years of age: potential impacts of schedule changes.
Saffar MJ; Fathpour GR; Parsaei MR; Ajami A; Khalilian AR; Shojaei J; Saffar H
J Trop Pediatr; 2011 Oct; 57(5):347-51. PubMed ID: 21078605
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
Sultana R; Rahman MM; Hassan Z; Hassan MS
Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
[TBL] [Abstract][Full Text] [Related]
6. Effect of highly active antiretroviral therapy on the serological response to additional measles vaccinations in human immunodeficiency virus-infected children.
Berkelhamer S; Borock E; Elsen C; Englund J; Johnson D
Clin Infect Dis; 2001 Apr; 32(7):1090-4. PubMed ID: 11264038
[TBL] [Abstract][Full Text] [Related]
7. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants.
Spoulou V; Giannaki M; Vounatsou M; Bakoula C; Grafakos S
Bone Marrow Transplant; 2004 Jun; 33(12):1187-90. PubMed ID: 15077129
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of antibodies to measles, mumps, and rubella, and serologic responses after vaccination among human immunodeficiency virus (HIV)-1 infected adults in Northern Thailand.
Chaiwarith R; Praparattanapan J; Nuket K; Kotarathitithum W; Supparatpinyo K
BMC Infect Dis; 2016 Apr; 16():190. PubMed ID: 27138005
[TBL] [Abstract][Full Text] [Related]
9. [Seroprevalence of antibodies against measles, rubella, mumps and varicella among school children in Madrid].
Gil Miguel A; Astasio Arbiza P; Ortega Molina P; Domínguez Rojas V; González López A
An Esp Pediatr; 1999 May; 50(5):459-62. PubMed ID: 10394183
[TBL] [Abstract][Full Text] [Related]
10. Immunity to Measles, Mumps, and Rubella in US Children With Perinatal HIV Infection or Perinatal HIV Exposure Without Infection.
Siberry GK; Patel K; Bellini WJ; Karalius B; Purswani MU; Burchett SK; Meyer WA; Sowers SB; Ellis A; Van Dyke RB; ;
Clin Infect Dis; 2015 Sep; 61(6):988-95. PubMed ID: 26060291
[TBL] [Abstract][Full Text] [Related]
11. Japanese encephalitis vaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy.
Puthanakit T; Aurpibul L; Yoksan S; Sirisanthana T; Sirisanthana V
Vaccine; 2007 Nov; 25(49):8257-61. PubMed ID: 17964009
[TBL] [Abstract][Full Text] [Related]
12. Response to measles, mumps, and rubella revaccination among HIV-positive and HIV-negative children and adolescents with hemophilia. Hemophilia Growth and Development Study.
Hilgartner MW; Maeder MA; Mahoney EM; Donfield SM; Evatt BL; Hoots WK
Am J Hematol; 2001 Feb; 66(2):92-8. PubMed ID: 11421305
[TBL] [Abstract][Full Text] [Related]
13. The urgent need for recommendations on revaccination of HIV-infected children after successful antiretroviral therapy.
Rainwater-Lovett K; Moss WJ
Clin Infect Dis; 2010 Sep; 51(5):634-5. PubMed ID: 20684683
[No Abstract] [Full Text] [Related]
14. Seroepidemiology of measles, mumps and rubella virus infections in normal children and adults in southern Granada, Spain: response to a vaccination programme.
Gutiérrez J; Rodríguez M; Huber E; Muñoz A; Piédrola G; Maroto C
Microbios; 1996; 88(356):143-8. PubMed ID: 9141711
[TBL] [Abstract][Full Text] [Related]
15. Measles, mumps, and rubella antibody status and response to immunization in children after therapy for acute lymphoblastic leukemia.
Aytac S; Yalcin SS; Cetin M; Yetgin S; Gumruk F; Tuncer M; Yurdakok K; Gurgey A
Pediatr Hematol Oncol; 2010 Aug; 27(5):333-43. PubMed ID: 20469978
[TBL] [Abstract][Full Text] [Related]
16. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
Zignol M; Peracchi M; Tridello G; Pillon M; Fregonese F; D'Elia R; Zanesco L; Cesaro S
Cancer; 2004 Aug; 101(3):635-41. PubMed ID: 15274078
[TBL] [Abstract][Full Text] [Related]
17. [Effects of measles vaccination in HIV infected children].
Ołdakowska A; Marczyńska M; Szczepańska-Putz M
Przegl Epidemiol; 2001; 55(4):523-7. PubMed ID: 11921741
[TBL] [Abstract][Full Text] [Related]
18. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M
An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
[TBL] [Abstract][Full Text] [Related]
19. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
Gerike E; Tischer A
Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
[TBL] [Abstract][Full Text] [Related]
20. Rubella susceptibility predicts measles susceptibility: implications for postpartum immunization.
Libman MD; Behr MA; Martel N; Ward BJ
Clin Infect Dis; 2000 Dec; 31(6):1501-3. PubMed ID: 11096023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]